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Cross-sectional studies have suggested a role for activation of adaptive immunity in smok-
ers with emphysema, but the clinical application of these findings has not been explored.
Here we examined the utility of detecting autoreactive T cells as a screening tool for
emphysema in an at-risk population of smokers.We followed 156 former and current (ever)-
smokers for 2 years to assess whether peripheral blood CD4 T cell cytokine responses to
lung elastin fragments (EFs) could discriminate between those with and without emphy-
sema, and to evaluate the relevance of autoreactive T cells to predict changes during
follow-up in lung physiological parameters. Volunteers underwent baseline complete phe-
notypic assessment with pulmonary function tests, quantitative chest CT, yearly 6-min
walk distance (6MWD) testing, and annual measurement of CD4T cell cytokine responses
to EFs. The areas under the receiver operating characteristic curve to predict emphy-
sema for interferon gamma (IFN-γ), and interleukin 6 (IL-6) responses to EFs were 0.81
(95% CI of 0.74–0.88) and 0.79 (95% CI of 0.72–0.86) respectively. We developed a dual
cytokine enzyme-linked immunocell spot assay, the γ-6 Spot, using CD4T cell IFN-γ and IL-6
responses and found that it discriminated emphysema with 90% sensitivity. After adjusting
for potential confounders, the presence of autoreactiveT cells was predictive of a decrease
in 6MWD over 2 years (decline in 6MWD, −19 m per fold change in IFN-γ; P =0.026, and
−26 m per fold change in IL-6; P =0.003). In support of the human association studies,
we cloned CD4 T cells with characteristic T helper (Th)1 and Th17 responses to EFs in the
peripheral blood of ever-smokers with emphysema, confirming antigenicity of lung elastin
in this population.These findings collectively suggest that the EF-specific autoreactive CD4
T cell assay, γ-6 Spot, could provide a non-invasive diagnostic tool with potential applica-
tion to large-scale screening to discriminate emphysema in ever-smokers, and predict early
relevant physiological outcomes in those at risk.
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INTRODUCTION
Tobacco smoke-induced diseases in humans represent some of
the most costly and deadly conundrums facing the world. In
human smokers and rodent models of smoke-induced emphy-
sema macrophages followed by neutrophils are recruited to the
lungs in large numbers; however, inconsistent with human dis-
ease, smoking cessation in mice results in clearance of many if not
all inflammatory changes (Guerassimov et al., 2004; Churg et al.,
2008). Only after discovery of adaptive immune B and T cells in
the lungs of former smokers with emphysema, did it become clear
that T cells might be responsible for perpetuating lung inflamma-
tion even following smoking cessation in susceptible individuals
(Saetta et al., 1998; Grumelli et al., 2004).
CD4 T cells that home to the lung secrete distinct repertoires
of cytokines that distinguish them into the T helper type 1 (Th1),
Th2, or Th17 cells which are identified by their signature cytokines,
namely interferon (IFN)-γ, interleukin (IL)-4, and IL-17 respec-
tively (Del Prete et al., 1993; Kamogawa et al., 1993; Muller et al.,
1993; Korn et al., 2009). Recent evidence points to a central role
for Th1 and Th17 cell trafficking to the lungs of smokers with
emphysema while similar findings have also been described in ani-
mal models of smoke-induced emphysema (Harrison et al., 2008;
Alcorn et al., 2009; Shan et al., 2009, 2012). What remains unclear
is whether specific adaptive immune responses directed against
aberrantly exposed antigen(s) could be used to detect human
emphysema in the at risk population.
Diseases marked by inflammation of elastin-rich organs such
as atherosclerosis of arteries, abdominal aortic aneurysms, and
emphysema have been associated with tobacco smoking and the
accumulation of inflammatory cells within the affected organs,
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and concurrently display elevated serum levels of soluble elastin
fragments (EFs; Kucich et al., 1991; Rosenbloom et al., 1991; Bizbiz
et al., 1997; Lindholt et al., 2001b; Petersen et al., 2002; Galk-
ina and Ley, 2009). We and others have shown that in addition
to macrophages and neutrophils that can directly secrete elastin
degrading enzymes, emphysematous lung harbors Th1 and Th17
cells that secrete cytokines and chemokines that further enhance
the release of matrix metalloproteinases (Grumelli et al., 2004;
Freeman et al., 2007; Kelsen et al., 2009; Shan et al., 2009).
Rapid decline in lung function is independently associ-
ated with emphysema severity in a subset of susceptible ever-
smokers although the underlying mechanisms that drive the pro-
inflammatory environment remain unknown (Mohamed Hoesein
et al., 2011; Vestbo et al., 2011; Nishimura et al., 2012). The pres-
ence of aggregates of T and B cells in the lung parenchyma of
smokers that correlated with disease severity indirectly support
a role for the adaptive immune system in disease modification
(Grumelli et al., 2004; Hogg et al., 2004). Similarly, the marked
abundance of IFN-γ and IL-17 secreting T cells in emphysematous
lung suggests a pathogenic role for autoimmune mediated inflam-
mation in emphysema (Shan et al., 2009). Nonetheless, the broader
physiological implications of elastin-reactive T cells remain unde-
fined and could be explored as a novel diagnostic tool to identify
ever-smokers with emphysema. We reasoned that fragments of
elastin could provide a source of newly exposed antigen that could
perpetuate the recruitment of autoreactive T cells and drive pro-
gressive inflammation, as seen in these ever-smokers (Lindholt
et al., 2001a; Debret et al., 2005).
In this study we aimed to determine whether detection of
highly specific T cell reactivity to EFs could discriminate emphy-
sema, and predict physiological outcome in an at risk population
of ever-smokers. In a cross-sectional study we validated that T
cell responses to two cytokines, IFN-γ and IL-6 and a newly
developed dual cytokine assay (γ-6 Spot), could discriminate
emphysema with 90% sensitivity. In a longitudinal study, we found
that ever-smokers with autoreactive immune phenotype manifest
exaggerated physiological decline over time. Finally we identified
smokers that harbor anti-elastin autoimmunity with confirmatory
cloning and characterization of CD4 T cells using specific major
histocompatibility cluster II (MHC-II) tetramers.
MATERIALS AND METHODS
STUDY PARTICIPANT PHENOTYPIC CHARACTERISTICS
We prospectively recruited 175 ever-smokers as part of the Lon-
gitudinal Exacerbation Study of Chronic Obstructive Pulmonary
Disease (LES-COPD). The demographic and schema of the enroll-
ment and the study population are shown in Table A1 and
Figure A1 in Appendix; the clinical characteristics of the volun-
teers have previously been described (Hesselbacher et al., 2011).
Briefly, enrollment criteria included age over 40, no history of con-
current lung cancer, chest surgery, or chronic lung diseases other
than COPD (e.g., sarcoidosis, fibrosis, etc.). Participants had no
history of allergies or asthma and at the time of initial recruitment
had not received oral or systemic corticosteroids during the pre-
vious 6 weeks; volunteers were enrolled from three clinics within
the Texas Medical Center in Houston, Texas: the Ben Taub General
Hospital, the Baylor Clinic, and the Michael E. DeBakey Veterans
Administration (VA) hospital. All studies were approved by the
Institutional Review Board at Baylor College of Medicine and
written informed consent was obtained from all study participants.
PULMONARY FUNCTION TESTING AND QUANTITATIVE CHEST
COMPUTED TOMOGRAPHY
All pulmonary function tests were performed in diagnostic labo-
ratories according to ATS/ERS guidelines (Pellegrino et al., 2005).
De-identified CT images were archived onto compact disks, sent
to the University of British Columbia (UBC), and were analyzed
using the previously validated EmphylxJ custom software (Coxson
and Rogers, 2005; Yuan et al., 2009). The CT attenuation of the
lung in Hounsfield units (HU) was calculated and used to assess
the percentage of emphysema (Coxson et al., 1995, 1999). Per-
cent Low Attenuation Area (%LAA), i.e., attenuation values below
−950 HU, of below 7% was used as the non-emphysematous lung;
this value has been validated by macroscopic and microscopic eval-
uation of lung tissue, which found that 6.8% LAA represents the
upper limit of non-emphysematous lung (Gevenois et al., 1995,
1996; Yuan et al., 2007, 2009).
T CELL BASED CYTOKINE ASSAYS
Peripheral blood mononuclear cells (PBMCs) were purified
using Ficoll-Paque Plus (GE Healthcare) centrifugation technique.
CD4+ T cells and CD14+/CD1a+ antigen presenting cells (APCs)
were enriched (>90% purity) by magnetic cell sorting (Mil-
tenyi Biotec) from 40 ml of heparinized blood. CD4+ T cells
(5× 105) were cultured in the presence of irradiated autologous
APC (5× 104), using a ratio of 1:10 APC to T cells. Duplicate wells
were stimulated with EFs (Elastin Products Company, Inc., MO,
USA) or were left untreated. The optimal concentration of EFs
(30µg/ml) was determined by dose response studies as previously
published and is consistent with the physiological concentration
of elastin in plasma (Bizbiz et al., 1997). Alternatively, 300µM
of designed 20-mer overlapping synthesized elastin peptides, or
15-mer elastin peptides identified by prediction algorithms to
match DR antigens (PEPscreen, Custom Peptide Libraries; Sigma
Genosys) were used to stimulate CD4+ T cells in vitro. After 3–
5 days of co-culture, supernatants were assayed for the presence of
IFN-γ, IL-6, IL-10, IL-13, and IL-17 by Luminex assay (Milliplex
Human Cytokine kit, Millipore, MA, USA).
The γ-6 Spot assay were set up using ELISpot plates (Milli-
pore) that were incubated overnight at 4˚C with 50µl capture
mAb mixture (anti-IFN-γ mAb at 5 mg/ml and anti-IL-6 mAb at
5 mg/ml, eBioscience). CD4+ T (2× 105) cells were isolated from
PBMC of emphysema and control volunteers and plated in serial
dilution in the presence or absence of 30µg/ml lung EFs for 24 h.
Captured cytokines were visualized as discrete spots by developing
with HRP-conjugated anti-IFN-γ- and biotin-conjugated anti-IL-
6 antibodies (R&D) and using BCIP/NBT and AEC chromogen
(Sigma).
REAGENTS, ANTIBODIES, AND FLOW CYTOMETRY
We designed 20 amino acids (20-mers) peptides, each with 10
overlapping sequences that cover all of the 786 amino acids of
human lung elastin (Vrhovski and Weiss, 1998; PEPscreen). Addi-
tional antibodies used in these studies were PerCP-conjugated
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anti-CD4 and anti-HLA-DR antibody (BD Biosciences, San Diego,
CA, USA), FITC-conjugated anti-CD44 antibody (eBioscience,
San Diego, CA, USA), and anti-CD4 and anti-CD1a conju-
gated paramagnetic microbeads (Miltenyi Biotec, Auburn, CA,
USA).
CD4+ T CELL CLONING AND TETRAMER STAINING
Cloning of CD4+ T cells using PBMC was accomplished with
a modified version of established protocols (Trainor and Morley,
1983; Mariotti and Nisini, 2009). Briefly,PBMC were re-suspended
in media (5% human serum) at 1× 106 cell/ml and were labeled
with the intracellular fluorescent dye carboxyfluorescein succin-
imidyl ester (CFSE). Cells were stimulated with EFs (30µg/ml;
Elastin Products Company, Inc., MO, USA) overnight. CFSE-
low populations that divided in response to EFs were isolated
using fluorescence activated cell sorting (FACS), distributed in
96-well plates, and stimulated for an additional of 5 days using
the same concentration of EFs. Wells were inspected for cell
growth and after recombinant human (rh)IL-2 (150 UI/ml; BD
Biosciences) stimulation, wells with optimal cell growth were
pooled and the T cell blasts were cloned under limiting dilu-
tion (0.5 cells/well) in the presence of allogeneic irradiated PBMC
(4× 105 cells/ml), 1 mg/ml phytohemagglutinin-L (Sigma), and
150 IU/ml rhIL-2. After 12–15 days, T cell clones were screened
and expanded using lung EFs or specific antigenic peptides that
were discovered within individual 20-mer overlapping synthetic
peptides. For tetramer staining, T cell clones or PBMC derived
T cells were stained with perCP-conjugated anti-CD4 antibody
(eBioscience) and APC-conjugated MHC-II tetramers specific for
specific elastin molecules (DRB1-0101/LLLLSILHPSRPGGV and
DRB1-0101/TGGVPGVGTPAAAAA), as well as a non-specific
tetramer hCLIP (DRB1-0101/PVSKMRMATPLLMQA) for 3 h at
37˚C. All tetramers were provided by the Tetramer Core Facility
of the National Institutes of Health (Emory University, Atlanta,
GA, USA). To increase the specificity of elastin-specific T cell
clones, a second round of subcloning was performed using lim-
ited dilution assay as described above. Specifically, the initial T
cell clones were stained with elastin peptide specific tetramer
described above, and the tetramer positive T cells were isolated
by FACS. Tetramer positive T cells were subsequently cloned
under limiting dilution described above and expanded using spe-
cific peptide (LLLLSILHPSRPGGV or TGGVPGVGTPAAAAA)
with a concentration of 300µM. The clones were inspected
daily and growing clones were harvested after 15 days for further
study.
SIX MINUTE WALK TEST: DISTANCE WALKED AND OXYGEN
DESATURATION
Volunteers underwent a baseline and yearly standard 6-min walk
test (6MWT) for 2 years (Crapo et al., 2002). Briefly, participants
were asked to walk for six consecutive minutes using standardized
instructions. Pulse oximetry readings (heart rate and O2 satura-
tion) were recorded at the start and every 10 s throughout the
walk. Total distance walked in 6-min (6MWD) and the lowest
oxyhemoglobin saturation were determined for each test. Oxygen
desaturation was defined as a drop to less than 90% O2 saturation
(Crapo et al., 2002).
STATISTICAL ANALYSIS
Comparisons of two sets of unpaired data were made using
Student’s t -tests and Mann–Whitney U test; paired data were
examined using paired t -tests or Wilcoxon singed rank tests. Cor-
relations were evaluated by Pearson or Spearman tests, and the
discriminatory ability of T cell responses was characterized by area
under the receiver operating characteristics (ROC) curve (AUC).
The optimal cutoff of T cell responses was determined by the
maximal Youden index (Youden, 1950). Multivariable linear and
negative binomial regression modeling were performed to evaluate
the associations of phenotypes with change in 6MWD and exacer-
bations, respectively. Model variables were selected a priori based
on medical literature, including age, sex, smoking status (cur-
rent and former), presence of coronary artery disease, body mass
index, and baseline FEV1. All analyses were performed using Stata
v11.1 software (StataCorp, College Station, TX, USA) or Prism
v5.0.2 (GraphPad Software, San Diego, CA, USA). All P values are
two-sided, with P < 0.05 considered statistically significant.
RESULTS
CD4+ T CELLS ARE FUNCTIONALLY DISTINGUISHABLE AND PERSIST IN
EMPHYSEMA
We determined whether stimulation of freshly isolated T cells from
ever-smokers with or without emphysema with lung-derived EFs
resulted in specific Th1 or Th17 cytokine production in vitro.
Freshly isolated CD4+T cells from PBMC of ever-smokers without
(controls; n= 61) or with emphysema (n= 95) that were stimu-
lated with lung EFs showed specific induction of IL-6, IL-17A,
and IFN-γ in emphysema (right three scatter plots) as compared
to controls (Figure 1A). There were no significant differences
in IL-10 or IL-13 production in CD4+T cells treated the same
way (Figure 1B). Interestingly, former smokers (open circle) with
emphysema showed T cell responses to EFs despite reported
(average of 12± 10 years) smoking cessation.
We next questioned whether elastin-specific T cell responses
that we identified at the time of recruitment into the study persist
in the same cohort over time. Therefore we measured CD4+ T cell
cytokine responses to EFs 10–24 months following the first assay in
randomly selected ever-smokers with (n= 45) or without (n= 32)
emphysema. We found that there is a large spectrum of the concen-
tration of cytokine secreted by CD4 T cells in response to EFs, but
ever-smokers with emphysema largely continued to show robust
T cells responses to EFs that both persisted and increased signif-
icantly when compared to the initial response (Figures 1C,D).
Notably, IFN- γ and IL-6 secretion in response to EFs did not sig-
nificantly change in the control group, indicating that increases
in EF-specific T cell cytokine secretion persist in ever-smokers
with emphysema. Although IL-17 response to EFs persisted in
the emphysema group, there was no increase in response and as
expected, there were no discernable changes in IL-10 or IL-13
responses in either group (data not shown).
PERIPHERAL BLOOD T CELL RESPONSE TO EFs CORRELATES WITH
DISEASE SEVERITY
We have previously reported a positive correlation between
increase in IFN-γ and IL-10, but not IL-4 or IL-13, responses
to EFs from CD4+ T cells isolated from former smokers with
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FIGURE 1 | CD4T cells are functionally distinguishable and persist in
emphysema. CD4+ T cells (5×105) and CD14+/CD1a+ APCs (5×104)
isolated from PBMC of emphysema (n=95) and control (n=61)
volunteers were co-cultured (10:1 ratio) for 3–5 days in the presence or
absence of lung elastin fragments (30µg/ml). The mean production IFN-γ,
IL-6, and IL-17, (A) and IL-10 and IL-13 (B) in the supernatants was
determined and the data were plotted as fold change over un-stimulated
(vehicle) conditions. Each circle represents one volunteer; open circles:
former smokers; closed circles: current smokers. Using the same T cell
and APC conditions, the concentrations of IFN-γ (C) and IL-6 (D) were
measured from EF-stimulated T cells obtained during a second clinic visit
(range 10–24 months following the initial measurement) from emphysema
(n=45) and control (n=32) volunteer. P values as indicated were
determined by the Mann–Whitney test.
emphysema severity (Lee et al., 2007). Consistently, in this much
larger cohort using a CD4+ T cells to APCs ratio (10:1), we
found a strong positive correlation between the production of
IFN-γ (r = 0.59, P < 0.0001) and IL-6 (r = 0.58, P < 0.0001),
and the severity of emphysema as determined by quantita-
tive CT scan (Figures 2A,B). CD4+ T cell secretion of IFN-γ
(r =−0.42, P < 0.0001) and IL-6 (r =−0.36, P < 0.0001) also
showed a significant positive correlation with the severity of air-
flow obstruction (Figure A2 in Appendix). While IL-17 secretion
by CD4+ T cells showed a modest correlation with the sever-
ity of emphysema, we found no significant correlation with the
degree of airflow obstruction as measured by FEV1% (Figure 2C,
and Figure A2 in Appendix). The production of IL-10 and
IL-13 in this large cohort further did not correlate with the
severity of emphysema or airway obstruction (Figure A2 in
Appendix).
DUAL CYTOKINE (IFN-γ AND IL-6) T CELL ASSAY DETECTS
EMPHYSEMA: γ-6 SPOT ASSAY
Given that CD4+ T cells isolated from peripheral blood sam-
ples in ever-smokers with emphysema (irrespective of airflow
obstruction) are functionally distinguishable from controls, and
the maximal Youden index (Youden, 1950) on the IFN-γ ROC,
we defined the threshold for a positive increase in T cell cytokine
responses to EFs at 1.5-fold increase over nil stimulation. The area
under the AUC for IFN-γ is 0.80 (95% CI of 0.74–0.88) and for
IL-6 is 0.79 with 95% CI of 0.72–0.86 (Figures 3A,B). We next
examined the number of individuals with or without emphysema
with more than a 1.5-fold increase in cytokine, and found that
the highest sensitivity (91%) corresponded to either a positive
IL-6 or IFN-γ response (Table 1). These data demonstrate that a
consistent response could be obtained from analyses of lympho-
cytes isolated from peripheral blood of ever-smokers. The striking
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FIGURE 2 | Peripheral bloodT cell response to elastin fragments
correlates with disease severity. The low attenuation area (%
emphysema) are plotted against the fold increase in production of (A)
IFN-γ, (B) IL-6, and (C) IL-17 by freshly isolated peripheral blood CD4+ T
cells (n=156) in response to elastin fragments (EFs) compared to nil
stimulation as described in Figure 1A. Dashed vertical line (7%)
represents the upper limit of normal value for quantification of
emphysema.
FIGURE 3 | Discriminatory ability of IFN-γ shown by the receiver
operating characteristics (ROC) curve and dual reporter cytokine (IFN-γ
and IL-6; γ -6 Spot) assay. (A) Fold change in IFN-γ and (B) IL-6 secreted from
T cells stimulated with elastin fragments (n=156). The area under the ROC
curve for IFN-γ is 0.8085 (95% CI of 0.74–0.88) and for IL-6 is 0.7912 with
95% CI of 0.72–0.86. (C) Dual color ELISpot assay showing cytokine
producing cells upon elastin stimulation from four representatives. Blue and
red spots indicate IL-6 and IFN-γ producing T cells, respectively.
sensitivity of the association between IFN-γ and/or IL-6 responses
in T cells stimulated with EFs and emphysema prompted us to
develop a PBMC-based assay that could be used as a screening tool
to discriminate emphysema in the same cohort. Therefore we next
developed an enzyme-linked immunospot (ELISpot) assay that
could simultaneously detect T cells expressing IFN-γ and IL-6
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Table 1 | Sensitivity and specificity of cytokines in CD4T cell.
Cytokine Control
(%LAA<7)
n=61
Emphysema
(%LAA>7)
n=95
Specificity
(%)
Sensitivity
(%)
IFN-γ 23 80 62 84
IL-6 32 84 48 88
IL-17 30 65 51 68
IFN-γ or IL-6 39 86 36 91
Table 2 | Sensitivity and specificity of γ-6 spot (ELISpot) assay.
Cytokine Emphysema
(n=59)
Control
(n=37)
Specificity Sensitivity
IFN-γ 46 8 78 78
IL-6 47 10 73 80
IFN-γ or IL-6 53 12 68 90
(γ-6 Spot) in response to EFs (Figure 3C). Consistent with the
cytokine studies we found that the increase in number of IL-6
and IFN-γ-secreting cells in response to 30µg/ml of EFs showed a
similar sensitivity and increased specificity as the cytokine assays
(Table 2).
ASSOCIATION BETWEEN AUTOREACTIVE T CELLS AND
PHYSIOLOGICAL DECLINE
The findings of elastin-specific T cells and autoreactive responses
to EFs strongly suggested a possible relationship between disease
progression as assessed by physiological decline and persistent sys-
temic autoimmune inflammation in ever-smokers. Because smok-
ing related decline in lung function is quite variable and thus a
relatively unreliable measurement of physiological decline, instead
we opted to use a measurement of physical activity, the 6-min walk
distance (6MWD) test (Figure A1 in Appendix). Univariate analy-
ses of the 6MWD (in meters) and secreted T cell IFN-γ and IL-6
showed a strong inverse association over 2 years (Figures 4A,B).
Multivariate analyses adjusting for potential confounders, includ-
ing age, sex, smoking status,baseline FEV1, coronary artery disease,
and body mass index, confirmed that the associations remained
significant (decline in 6MWD, −19 m per fold change in IFN-γ;
P = 0.026, and,−26 m per fold change in IL-6; P = 0.003). There
was no significant association between 6MWD and fold change
in IL-17, IL-10, or IL-13 (Figure A3 in Appendix). In support
of the observed decline in physiological capacity, we also found
that individuals with reduced oxygen saturation during annual
6MWT showed significantly greater CD4+ T cell response to EFs
as evidenced by higher IFN-γ (P = 0.0002) and IL-6 (P < 0.0001)
fold induction when compared to those without reduced oxygen
saturation (Figures 4C,D). Multivariate analyses revealed no asso-
ciations between cytokine production and outpatient respiratory
infections, COPD-related hospitalizations, or non-COPD hospi-
talizations (data not shown). Thus, elastin-specific autoimmune
reactivity can be detected by standard immunological assays and
persistence of autoreactive T cells in peripheral blood portends
disease progression as assessed by decreases in relevant functional
parameters.
FIGURE 4 | Longitudinal study of association between autoreactiveT
cells and physiological decline. The change in 6-min walk distance
(6MWD) in meters over 2 years is plotted against the fold change of CD4+ T
cells in ever-smokers (n=90) with emphysema (A) IFN-γ and (B) IL-6 in
response to elastin fragments over nil stimulation; r =−0.35, P =0.0006
for IFN-γ and r =−0.41, P <0.0001 for IL-6). The production of IFN-γ [(C),
red] and IL-6 [(D), blue] by peripheral blood CD4+ T cells stimulated by
elastin fragments is plotted in volunteers that had oxygen desaturation
(filled circles, n=62) during the initial or subsequent 6-min walk tests and
those that did not (open circles, n=35). Significantly higher levels of IFN-γ
(P = 0.0002) and IL-6 (P <0.0001) were measured in volunteers with
oxygen desaturation.
IDENTIFICATION OF ELASTIN-SPECIFIC T CELL EPITOPES
The preceding findings corroborate that elastin-specific Th1 and
Th17 cells persist in peripheral blood of ever-smokers with emphy-
sema. Although the findings are highly specific, they were derived
using commercially available, human lung EFs that are created
using neutrophil elastase digestion (Starcher and Galione, 1976).
Thus, to explore the immunogenic nature of elastin, we synthe-
sized 78 overlapping 20 amino acid (20-mers) long peptides that
span the entire length of the molecule (Figure A4 in Appendix).
In the first screen of peptides that were pooled into 8 groups, as
depicted using spray plots, we found that peptides in groups 1
and 5, shown in red and green, elicited the most significant and
consistent increases (at least 50% over vehicle control) in secre-
tion of IFN-γ, IL-6, IL-17A from CD4+ T cells when compared to
other peptide pools (e.g., groups 2–4, and 6–8; Figure 5). These
findings were specific to ever-smokers with emphysema because
examination of CD4+ T cells in controls (ever-smokers without
emphysema) with positive T cell responses to EFs of greater than
50% increase, did not identify the same regions within the pep-
tide sequences (Figure A5 in Appendix). The existence of many
potential T cell elastin epitopes is suggested by the positive T cell
responses in all peptide pools that we tested (Figures 5A–C).
However, to further pinpoint the specific epitopes and because of
the consistently higher responses seen in groups 1 and 5, CD4+
T cells from those with emphysema were subsequently stimulated
with individual overlapping 20-mer peptides within the amino
acids 1–100 and 401–500. As expected, many, but not all, peptide
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FIGURE 5 | Overlapping elastin peptides contain multipleT cell
epitopes. Seventy eight overlapping peptides 20 amino acids (20-mer) in
length spanning human elastin were synthesized and pooled into 8
groups designated with eight different colors (described in Figure A4 in
Appendix). CD4+ T cells (5×105) were co-cultured with
CD14+/CD1a+(5×104) autologous APCs in the presence or absence of
20-mers (300µM) in each group. Fold increase over nil stimulation in
secreted IFN-γ (A) IL-6 (B) and IL-17 (C) are shown in 2 combined groups
per spray plot; n=39. The numbers corresponding to each color indicate
the numbers of individuals with a positive (>1.5-fold increase) response
over nil stimulation. Using the same T cell/APC assay, IFN-γ fold increase
induced by each 20-mer (1–10) within (D) group 1 (shown in red) and (E)
group 5 (shown in green) were plotted as fold increase relative to nil
stimulation; each dot represent one volunteer; n=27 for group 1, n=16
for group 5. Lung elastin fragments (EFs; 30µg/ml) were used as positive
control. Veh, vehicle control.
sequences in these two pools elicited significant increases in IFN-γ
secretion from CD4 T cells (Figures 5D,E). These findings con-
firm that elastin epitope-specific Th1 and Th17 cells are selectively
present in the peripheral blood of ever-smokers with emphysema.
CD4+T CELL CLONES RESPOND TO ELASTIN FRAGMENTS
We next used PBMCs that were isolated from participants with
the most robust immune responses to EFs to clone elastin-specific
T cells. Four of the eight volunteers that we studied yielded mul-
tiple elastin-specific CD4+ T cell clones that responded to EFs
with greater than 50% increase in IFN-γ and IL-6 secretion (data
not shown). Based on the in vitro T cell activation studies using
synthetic 20-mer overlapping elastin peptides, we searched predic-
tion engines1,2 to find sequences known to bind a common class II
MHC molecule (DRB1) with high affinity and found three puta-
tive 15-mer peptide sequences. We designed and synthesized two
peptides that induced the strongest cognate cytokine secretion in
T cells and had the highest predicted binding scores, belonging to
group 1 and group 5 peptides designated as peptides 1 (LLLLSILH-
PSRPGGV) and peptide 2 (TGGVPGVGTPAAAAA), respectively.
We next isolated T cells from the peripheral blood of patients
with a strong cytokine response to elastin stimulation using cells
labeled with the intracellular fluorescent dye CFSE. T cells with low
CFSE were isolated with a flow sorter and were stained with two
MHC-II tetramers using the same identified immunodominant
1www-bimas.cit.nih.gov
2www.syfpeithi.de/
elastin peptide 1 and peptide 2 that we had used to validate their
immunogenic properties. We found tetramer positive staining in
several cloned T cells for one or both tetramers (Figure 6A, and
data not shown), therefore to increase the purity of T cells respond-
ing to elastin, we sorted tetramer positive T cells and performed a
second round of T cell cloning using limiting dilution technique
(Trainor and Morley,1983). Consistently, a CD4+ T cell clone (e.g.,
378-4-1) with over 40% detectable tetramer 1 staining secreted
higher concentration of IL-6 and IFN-γ in response to elastin
peptide 1, while no significant response was detected with peptide
2 stimulation under the same conditions (Figures 6A,B). Simi-
larly, tetramer 2 staining was detected in over 30% of T cell clones
(e.g., 378-7-1) that specifically responded to peptide 2, but not
peptide 1 (Figures 6A,C). Further, anti-DR blocking antibodies
either partially or fully inhibited IL-6 and IFN-γ secretion, indi-
cating specific MHC-II dependent antigen responses to peptides 1
and 2 (Figures 6B,C).
To confirm the presence of autoreactive elastin-specific T cells,
we used freshly isolated CD4+ T cells from control and emphy-
sema volunteers and determined the relative abundance of elastin
tetramer positive T cells. We found that while some CD4+ T cells
in emphysema had increased relative abundance of elastin positive
tetramers without any stimulation, in most cases, up to 10-fold
increase in T cell binding to the tetramers was found following
3 days of T cell stimulation with EFs (Figures 7A,B and Figure A6
in Appendix). Therefore, we assessed the relative abundance of
tetramer positive CD4+ T cells following 3 days of culture with
EFs in controls and emphysema volunteers. We found a higher
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FIGURE 6 | Cloning and characterization of EF-specific CD4T cells. (A)
Representative flow cytometry plot for two different CD4+ T cell clones
that were stained with antibody to CD4 (perCP-conjugated) and APC-
conjugated MHC-II tetramers specific for elastin molecule (DRB1-0101/
LLLLSILHPSRPGGV and DRB1-0101/TGGVPGVGTPAAAAA), as well as a
non-specific tetramer hCLIP (DRB1-0101/PVSKMRMATPLLMQA) are
shown. Relative % abundance of tetramer positive CD4+ T cells is shown
above each of the gated area in the plots. Data are representative of three
independent assays. Representative measurement of IL-6 secretion in T cell
clones (B,C) in response to peptide 1 and peptide 2 (300µM each) as
described in experimental condition above (A). Data are mean± s.e.m. of
three measurements, represents one of six independent studies.
∗P <0.05; determined by the Student’s t -test comparing to the baseline T
cell cytokine measurement.
proliferation response, and a larger relative abundance of tetramer
positive CD4+ T cells when compared to controls (Figures 7A–
D). The same individuals showed significantly increased T cell
cytokine responses to EFs, confirming that the pathogenic T cells
secrete IFN-γ and IL-6 in an antigen-specific manner (Figure 7B).
Notably, the same T cells failed to secrete IL-13 and IL-10 under
the same conditions (data not shown).
DISCUSSION
In this comprehensive study, we report the first description of a
screening assay designed to discriminate emphysema and provide
the results of a longitudinal study that links T cell immune profiles
with physiological decline among ever-smokers. Using emphy-
sema as the main hallmark of smoking-induced lung damage,
peripheral blood CD4+ T cell immune responses to elastin consis-
tently discriminated those with and without disease over 2 years of
follow-up. Furthermore, we discovered that the discriminatory T
cell cytokine signature consisted of IFN-γ and IL-6, and to a lesser
extent IL-17A. EF-specific induction of these cytokines was signifi-
cantly increased in those with emphysema irrespective of smoking
status and baseline FEV1 (both were controlled for in multivariate
analyses), and was associated with a rapidly progressive decline in
physiological function.
Several important findings emerge from our investigations and
description of the autoreactive T cells screen assay that discrim-
inate emphysema in ever-smokers. First, using the host immune
response, we addressed the longstanding question regarding the
remarkable heterogeneity seen in disease expression and pro-
gression in smokers with similar smoking histories that typically
spans a spectrum ranging from no disease to the most severe
and debilitating forms of lung destruction (Agusti et al., 2010;
Han et al., 2010). Our findings here may shed new light on
this well known clinical observation, as evidenced by the fact
that not all ever-smokers develop autoreactive T cells. While
many genetic factors shape individual responses to environmen-
tal insults such as cigarette smoke, our findings here point to
the need to define the genetic basis of elastin autoimmunity
induced by exposure to cigarette smoke (Kheradmand et al.,
2012).
Detection of autoreactive T cells and its inverse association
with accelerated physiological decline, as we show here, supports
the hypothesis that T cells responses to elastin might be a poor
prognostic indicator in a subset of ever-smokers. In addition to
conventional T cell restimulation assays used to determine the
presence of elastin-specific immunity, such prognostic studies
could also include the use of tetramer technology to more rapidly
detect and quantify elastin-specific T cells, as we applied for the
first time here. Identification of the immunodominant peptides
within EFs provides the exciting possibility that autoreactive cells
could be suppressed using alteration of the immune response,
thus providing a uniquely specific therapy for emphysema. Fur-
ther long-term and independent cohort studies are required to
establish the feasibility of the prognostic and therapeutic strategies
suggested by our findings.
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FIGURE 7 | Increased relative abundance of elastin positive tetramers in
emphysema. (A) Representative flow plots of controls (n=5) and
emphysema (n=7) cases for freshly isolated CD4+ T cells from control and
emphysema that were stimulated with elastin fragments (EFs) for 3 days and
were stained with elastin-specific and control tetramers as described in
Figure 6C. Relative % abundance of tetramer positive CD4+ T cells is shown
above each of the gated area in the plot. (B) IFN- γ and IL-6 fold change in
response to elastin fragment (30µg/ml) over nil stimulation for the
corresponding patients. Cytokine concentrations were measured by
LINCOplex. (C) Representative histograms of CD4+ T cells CFSE-labeled
isolated from PBMC of control or emphysema volunteers cultured overnight
in the presence (blue lines) or absence (red filled lines) of elastin fragments
(30µg/ml). Unlabeled control cells are shown in solid green lines. (D)
Cumulative relative % abundance of tetramer positive CD4+ T cells in controls
(n=5) and emphysema (n=7) for tetramer 1 and 2 as well as a non-specific
tetramer hCLIP as described in Figure 6A.
Unlike the well-accepted Global initiative on Obstructive Lung
Disease (GOLD) staging system that defines specific COPD strata
based on measurements of airflow obstruction, there exists no
similar classification of emphysema (GOLD Executive Commit-
tee, 2008). Because the aim of our investigation was to determine
whether autoimmune T cells in lifetime ever-smokers could dis-
criminate lung parenchymal disease, we used CT-based quantita-
tion of emphysema and not pulmonary function-based analyses of
airflow obstruction (Gevenois et al., 1995, 1996; Yuan et al., 2007,
2009). Importantly, our findings demonstrate that, irrespective of
lung function status, the presence of elastin-specific CD4+ T cells
in the peripheral blood correlates with the degree of emphysema.
Airflow limitation is not an inevitable consequence of emphy-
sema and, indeed, the mechanisms governing reduced airflow in
emphysema are not well understood. Not surprisingly, therefore,
attempts to use indices of lung function to predict clinically rele-
vant outcomes in smokers have shown mixed success (Highland
et al., 2003; Lapperre et al., 2009; Han et al., 2010). In contrast,
our ability to correlate elastin-specific T cell responses in smok-
ers to declines in functional performance in the 6MWT point to
the fundamental importance of autoimmunity in lung disease in
smokers.
The importance of IFN-γ and IL-17A in autoimmunity has
been established in both humans and animal models (Littman and
Rudensky, 2010). Neurodegeneration in multiple sclerosis, syn-
ovial inflammation in rheumatoid arthritis, inflammatory bowl
disease, and type I diabetes have all been shown to be in part
mediated by IL-17A and IFN-γ (Toh and Miossec, 2007; Yamada
et al., 2008; Uhlig and Powrie, 2009; Durant et al., 2010; Kaser et al.,
2010). Moreover, the harmful role of IL-17 in autoinflammatory
diseases has been defined through the beneficial effect of neutral-
ization of this cytokine in clinical studies involving autoimmune
disorders (Hueber et al., 2010). Therefore, given the autoimmune
nature of emphysema, our human translational studies suggest
that therapies that neutralize IL-17, IFN-γ, and related cytokines
in ever-smokers with emphysema manifesting increased T cell
responses to EFs might be similarly effective. While the exact
contribution of these cytokines in progression of autoimmune
diseases is an intense area of investigation, multiple susceptibility
loci have been associated with the reduction of immune tolerance
to self-antigens that most likely drive development of autoreactive
T cells (Lettre and Rioux, 2008).
In addition to increased secretion of IFN-γ and IL-17 from
autoreactive T cells, we have also identified IL-6, a pleotropic
cytokine that together with TGF-β is required for differentiation
of native T cells into pathogenic Th17 cells (Chang and Dong,
2011). Human studies have shown increased IL-6 serum con-
centrations with age that associate with specific single nucleotide
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polymorphisms (SNPs) in the IL-6 gene, but there was no evi-
dence found for an association between common variations in
this gene and adverse health outcomes in a population of older
adults (Walston et al., 2007). While a retrospective study using two
large cohorts identified three IL-6 SNPs that are associated with a
rapid decline in lung function (He et al., 2009), it should be noted
that none of the haplotypes were associated with an increase in
basal levels of IL-6, suggesting that the identified SNPs are most
likely not a single determinant of basal secretion of serum IL-6.
While we did not evaluate the basal concentration of any cytokine
in the serum of our cohort, we found that there was a large vari-
ability in the baseline secretion of IL-6 from T cells that did not
discriminate ever-smokers with or without emphysema (data not
shown); however we found that T cell responses to EFs resulted in
a significant and sustained increase in IL-6 secretion.
The immune profile in those with emphysema may be distinct
from those with predominant airway obstruction because, while
they were both associated with the production of IFN-γ and IL-6 in
response to EFs, only emphysema severity but not airway obstruc-
tion correlated with the magnitude of IL-17 production. Thus,
production of IL-6 and IL-17 in response to lung antigen is seen in
ever-smokers with emphysema, but IFN-γ is produced most con-
sistently in those with both airflow obstruction and emphysema,
possibly because these smokers tend to have more severe disease.
In parallel to the possible role of autoimmune mediated recruit-
ment of inflammatory cells to the lungs, proteolytic cleavage of
matrix molecules has been shown to provide the necessary envi-
ronmental factors associated with human COPD (Senior et al.,
1984; van Houwelingen et al., 2008). In particular, collagen degra-
dation can elaborates N -acetyl Pro-Gly-Pro (PGP) tripeptides that
act as a potent neutrophil chemoattractants in vivo, a process that is
mediated through activation of CXCR2 (Weathington et al., 2006).
Our findings demonstrate that in addition to the role of PGPs, the
presence of elastin autoreactive T cells in peripheral blood portend
disease progression over time.
The observational nature of this study makes it impossible
to determine a causal relationship between phenotype in ever-
smokers and the associated clinical impact noted. Furthermore,
because of the significant difference in the elastin composition
of the lungs in human (24%) and rodents (2.4%; Starcher and
Galione, 1976), smoke-induced lung disease in inbred strains of
mice most likely will not provide the exact immunological fea-
tures as those found in humans with emphysema. Nonetheless,
identifying the factors that specifically lead to destructive changes
in human emphysema and in animal models of smoke-induced
emphysema, are needed for understanding the pathogenesis of a
potentially disabling and fatal response to cigarette smoke.
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APPENDIX
FIGURE A1 | Schematic overview of the study design. Abbreviations:
CT, computed tomography; 6MWT, 6-min walk test; 6MWD, 6-min walk
distance; SpO2, peripheral oxyhemoglobin saturation. aThirty eight
subjects did not complete 2-year follow-up of 6MWT: 16 were lost to
follow-up or withdrew consent, 9 did not have sufficient time from
baseline to complete 2 years, 8 due to illnesses other than respiratory
health, 2 due to scheduling conflicts, 2 due to frequent respiratory
exacerbations, 1 expired.
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FIGURE A2 | Cytokine responses to elastin fragments and correlation
with disease severity. (A) The correlation between low attenuation area (%
emphysema), and (B) forced expiratory volume in 1 s % predicted (FEV1%)
are plotted against the fold increase in production of IL-10, and IL-13 by freshly
isolated peripheral blood CD4+ T cells (n=112) in response to elastin
fragment compared to nil stimulation as described in Figure 1 legend. (C)
forced expiratory volume in 1 s % predicted (FEV1%) are plotted against the
fold increase in production of IFN-γ, IL-6, and IL-17 by freshly isolated
peripheral blood CD4+ T cells (n=156) in response to elastin fragments (EFs)
compared to nil stimulation as described above.
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FIGURE A3 | Longitudinal study of association between IL-17, IL-10, and
IL-13 in autoreactiveT cells and physiological decline. The change in 6-min
walk distance (6MWD) in meters, over 2 years is plotted against the fold
change of CD4+ T cells in ever-smokes (n=90) in IL-17, IL-10, and IL-13 in
response to elastin fragments over nil stimulation. No significant associations
were found among these three cytokines and changes detected in 6MWD.
FIGURE A4 | Schematic representation of the 20-mer elastin peptides
and pooled groups. (A) Twenty amino acid (20-mer) peptides were
synthesized that span the entire human elastin molecule and were grouped
into 8 pools. (B) Each pooled groups were added to CD4+ T cell (5×105) and
CD1a+ APCs (5×104) for 3–5 days. Supernatant were collected and stored at
−80 for batch analysis of selected cytokines using LINCOplex assay.
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FIGURE A5 | Spray plot of cytokines secreted inT cells isolated from
ever-smoker controls. Seventy eight overlapping peptides 20 amino acids
(20-mer) in length spanning human elastin were synthesized and pooled into
8 groups designated with eight different colors (described in Figure A4 in
Appendix). CD4+ T cells (5×105) were co-cultured with CD1a+ (5×104) APCs
isolated in control ever-smokers without emphysema in the presence or
absence of 20-mers (300µg/ml) in each group. Fold increase over nil
stimulation in secreted IFN-γ are shown in 2 combined groups per spray plot;
n= 9. Numbers on top of each spray plot represents the specific pooled
group as described in Figure A4 in Appendix).
FIGURE A6 | Elastin fragments increases relative abundance of
%Tetramer positive CD4T cells. Flow cytometry plot for freshly isolated
CD4 T cells that were stimulated without (vehicle) or with elastin fragments
(EFs; 30µg/ml) stained with antibody to CD4 (perCP-conjugated) and
APC-conjugated MHC-II tetramers specific for elastin molecule
(DRB1-0101/LLLLSILHPSRPGGV and DRB1-0101/TGGVPGVGTPAAAAA), as
well as a non-specific tetramer hCLIP (DRB1-0101/PVSKMRMATPLLMQA) are
shown. Relative % abundance of tetramer positive CD4+ T cells is shown
above each of the gated area in the plots. Representative of a subject
showing (A) approximately 10-fold increase or (B) moderate increase in
relative % abundance of Tet1 and Tet 2 in response to EFs stimulation. Data
are representative of three independent assays.
Frontiers in Immunology | Inflammation August 2012 | Volume 3 | Article 267 | 16
Xu et al. T cell assay in human emphysema
Table A1 | Clinical and demographic information of the study participants.
Group Controls Emphysema
Number 61 95
Age, mean (±s.d.) 55±9 62±9
Height, cm (±s.d.) 170±10 175±8
Weight, kg (±s.d.) 83±18 87±20
BMI, kg/m2 (±s.d.) 29±6 28±7
Male, no. (%) 31 (51%) 79 (83%)
ETHNICITY, NO. (%)
Black 32 (52%) 29 (31%)
Hispanic 3 (5%) 4 (4%)
White 25 (41%) 61 (64%)
Other 1 (2%) 1 (1%)
SMOKING STATUS, NO. (%)
Current 46 (75%) 38 (40%)
Former 15 (25%) 57 (60%)
Never 0 (0%) 0 (0%)
Pack-years, mean (±s.d.) 47±41 58±37
Quitting years, mean (±s.d.) 13±14 11±10
LUNG FUNCTION
% FEV1 (± s.d.) 83±19 62±25
FEV1/FVC ratio (±s.d.) 73±10 54±16
%LAA (±s.d.) 3±2 21±11
*s.d., Standard deviation; cm, centimeters; kg, kilograms; BMI, body mass index; no., number; %FEV1, forced expiratory volume in 1 s, percent of predicted; FVC,
forced vital capacity; pack-years, number of years smoked × packs per day; quitting years, number of years since last reported smoking activity; %LAA, % low
attenuation area (−950 HU) by CT quantification.
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